Key result
Mid-ventricular obstruction in HOCM is linked to ~169% higher NSVT risk.
Why the study?
Mid-ventricular obstruction is associated with ventricular arrhythmia, but its relationship with non-sustained ventricular tachycardia in hypertrophic cardiomyopathy patients was unknown.
Does the presence of mid-ventricular obstruction increase the incidence of non-sustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy?
Cohort (n=572)
No
Does the presence of mid-ventricular obstruction increase the incidence of non-sustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy?
Effect estimate: OR 2.69 (95% CI 1.41-5.13)
Absolute Event Rate: 22.4% vs 11.1%
p-value: p=.003
In patients with hypertrophic obstructive cardiomyopathy, the presence and severity of mid-ventricular obstruction are independently associated with a higher risk of non-sustained ventricular tachycardia.
BACKGROUND: Mid-ventricular obstruction (MVO) is a rare subtype of hypertrophic cardiomyopathy (HCM) but it is associated with ventricular arrhythmia. The relationship between MVO and non-sustained ventricular tachycardia (NSVT) in HCM patients is unknown. HYPOTHESIS: The severity of MVO increases the incidence of NSVT in patients with hypertrophic obstructive cardiomyopathy (HOCM). METHODS: Five hundred and seventy-two consecutive patients diagnosed with HOCM in Fuwai Hospital between January 2015 and December 2017 were enrolled in this study. Holter electrocardiographic and clinical parameters were compared between HOCM patients with and without MVO. RESULTS: Seventy-six (13.3%) of 572 patients were diagnosed with MVO. Compared to patients without MVO, those with MVO were much younger, and had a higher incidence of syncope, greater left ventricular (LV) posterior wall thickness, a higher percentage of LV late gadolinium enhancement, and higher prevalence of NSVT. Furthermore, the prevalence of NSVT increased with the severity of MVO (without, mild, moderate or severe: 11.1%, 18.2%, 25.6%, respectively, p for trend < .01). Similarly, the prevalence of NSVT differed among patients with isolated LV outflow tract (LVOTO), both MVO and LVOTO, and isolated MVO (11.1%, 21.3%, 26.6%, respectively, p for trend = .018). In addition to age, diabetes, left atrial diameter, and maximal wall thickness, multivariate analysis revealed the presence of MVO as an independent risk factor for NSVT (Odds ratio 2.69; 95% confidence interval 1.41 to 5.13, p = .003). CONCLUSIONS: The presence and severity of MVO was associated with higher incidence of NSVT in HOCM patients.
No takes yet. Share an insight, caveat, or question.
Nie et al. (2021) conducted a cohort in Hypertrophic obstructive cardiomyopathy (n=572). Mid-ventricular obstruction vs. Without mid-ventricular obstruction was evaluated on Non-sustained ventricular tachycardia (NSVT) (OR 2.69, 95% CI 1.41-5.13, p=.003). The presence of mid-ventricular obstruction in patients with hypertrophic obstructive cardiomyopathy was an independent risk factor for non-sustained ventricular tachycardia (OR 2.69).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: